Single intravenous dose of oritavancin for treatment of acute skin and skin structure infections caused by gram-positive bacteria: Summary of safety analysis from the phase 3 SOLO studies

  1. Corey, G.R.
  2. Loutit, J.
  3. Moeck, G.
  4. Wikler, M.
  5. Dudley, M.N.
  6. O'Riordan, W.
  7. Abete, J.F.
  8. Altmeyer, P.
  9. Basson, M.D.
  10. Bezrodnyi, B.G.
  11. Brennan, R.O.
  12. Bubnova, N.A.
  13. Chandra, A.
  14. Chandrasekharan, A.A.
  15. Chen, J.
  16. Condrea, C.
  17. Del Rayo Morfin, M.
  18. DeValle, O.
  19. Dunbar, L.
  20. Duttarroy, D.
  21. Giordano, P.
  22. Gonzalez, J.
  23. Gorgolas, M.
  24. Graham, D.R.
  25. Green, S.
  26. Gudz, I.
  27. Gupta, S.K.
  28. Heller, B.N.
  29. Hussein, O.
  30. Jauregui-Peredo, L.
  31. Kabler, H.
  32. Kazimir, M.
  33. Keech, R.C.
  34. Kelkar, D.
  35. Konychev, A.V.
  36. Koura, F.
  37. Kozlov, R.S.
  38. Laboranti, M.C.
  39. Lakhani, R.J.
  40. Lee, P.C.
  41. Leiman, D.
  42. Leiva, J.
  43. Lenskaya, L.G.
  44. Levchik, E.Y.
  45. Lombana-Martinez, C.
  46. Lucasti, C.
  47. Mahakalkar, C.C.
  48. Mannis, S.H.
  49. Manos, P.J.
  50. Marinescu, S.A.
  51. Mayakonda, R.K.
  52. McKinnell, J.
  53. Mehra, P.
  54. Minkowitz, H.
  55. Nagappa, Y.C.
  56. Nolan, P.
  57. Osiyemi, O.
  58. Overcash, J.S.
  59. Porwal, A.D.
  60. Pullman, J.
  61. Pyptiuk, O.
  62. Perez, N.Q.
  63. Rahav, G.
  64. Ramachandra, H.T.
  65. Reinhardt, J.
  66. Riesenberg, K.
  67. Rodoman, G.
  68. Romero-Cabello, R.
  69. Rozario, A.P.
  70. Shah, M.Y.A.S.
  71. Sandesc, D.
  72. Schlesinger, Y.
  73. Sears, W.K.
  74. Shapoval, S.D.
  75. Shulutko, A.
  76. Sims, M.
  77. Singh, R.
  78. Stenstrom, R.J.
  79. Tuckler, V.
  80. Voigt, D.
  81. Zaichuk, A.
  82. Zeltser, D.
  83. Zubareva, N.A.
  84. Erakutsi egile guztiak +
Aldizkaria:
Antimicrobial Agents and Chemotherapy

ISSN: 1098-6596 0066-4804

Argitalpen urtea: 2018

Alea: 62

Zenbakia: 4

Mota: Artikulua

DOI: 10.1128/AAC.01919-17 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak